Results of a double-blind, randomized, dose-titration, placebo controlled multicenter trial (SCO/BIA-2093-203 study) on safety and efficacy of eslicarbazepine acetate (BIA 2-093) for acute manic episodes associated with biopolar I disorder

被引：0
|
作者：
Robertson, B. [1 ]
Grunze, H. [2 ]
Versavel, M. [1 ]
Costa, R.
Almeida, L. [3 ]
Soares-da-Silva, P.
机构：
[1] Sepracor Inc, Marlborough, MA USA
[2] Klinikum Univ Munchen, Klin Psychiat & Psychotherapie, Munich, Germany
[3] Univ Porto, Inst Pharmacol & Therapeut, Oporto, Portugal
来源：
BIPOLAR DISORDERS | 2010年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：46 / 46
页数：1
相关论文
共 9 条
  • [1] Efficacy and Safety of Adjunctive Armodafinil in Adults With Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
    Calabrese, Joseph R.
    Frye, Mark A.
    Yang, Ronghua
    Ketter, Terence A.
    JOURNAL OF CLINICAL PSYCHIATRY, 2014, 75 (10) : 1054 - +
  • [2] A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole for the treatment of acute manic or mixed episodes in Asian patients with bipolar I disorder (the AMAZE study)
    Kanba, Shigenobu
    Kawasaki, Hiroaki
    Ishigooka, Jun
    Sakamoto, Kaoru
    Kinoshita, Toshihiko
    Kuroki, Toshihide
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2014, 15 (02): : 113 - 121
  • [3] A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole for the treatment of acute manic or mixed episodes in Asian patients with bipolar I disorder (The AMAZE Study)
    Kawasaki, H.
    Kanba, S.
    Kuroki, T.
    BIPOLAR DISORDERS, 2012, 14 : 88 - 88
  • [4] Randomized, double-blind, placebo-controlled, dose-response study of paliperidone extended-release tablets for acute manic and mixed episodes in bipolar I disorder
    Berwaerts, J.
    Xu, H.
    Nuamah, I.
    Lim, P.
    Hough, D.
    BIPOLAR DISORDERS, 2009, 11 : 20 - 20
  • [5] Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study
    Daniel E. Casey
    Earl E. Sands
    Jens Heisterberg
    Hwa-Ming Yang
    Psychopharmacology, 2008, 200 : 317 - 331
  • [6] Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study
    Casey, Daniel E.
    Sands, Earl E.
    Heisterberg, Jens
    Yang, Hwa-Ming
    PSYCHOPHARMACOLOGY, 2008, 200 (03) : 317 - 331
  • [7] Efficacy and Safety of Low- and High-Dose Cariprazine in Acute and Mixed Mania Associated With Bipolar I Disorder: A Double-Blind, Placebo-Controlled Study
    Calabrese, Joseph R.
    Keck, Paul E., Jr.
    Starace, Anju
    Lu, Kaifeng
    Ruth, Adam
    Laszlovszky, Istvan
    Nemeth, Gyoergy
    Durgam, Suresh
    JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (03) : 284 - 292
  • [8] Asenapine: Efficacy and safety of 5 and 10 mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I disorder
    Landbloom, Ronald L.
    Mackle, Mary
    Wu, Xiao
    Kelly, Linda
    Snow-Adami, Linda
    McIntyre, Roger S.
    Mathews, Maju
    Hundt, Carla
    JOURNAL OF AFFECTIVE DISORDERS, 2016, 190 : 103 - 110
  • [9] Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) Trial: A Global Phase 3 Double-Blind, Randomized, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Prasugrel in Pediatric Patients With Sickle Cell Anemia Utilizing a Dose Titration Strategy
    Hoppe, Carolyn C.
    Styles, Lori
    Heath, Lori E.
    Zhou, Chunmei
    Jakubowski, Joseph A.
    Winters, Kenneth J.
    Brown, Patricia B.
    Rees, David C.
    Heeney, Matthew M.
    PEDIATRIC BLOOD & CANCER, 2016, 63 (02) : 299 - 305
1